Resources | Association for Accessible Medicines

AAM Statement - President Trump’s Blueprint to Lower Drug Prices

Jun 22, 2018 | Rachel Schwartz

AAM Announces Additional 2018 Associate Members

Jun 22, 2018 | Rachel Schwartz

AAM Announces New Regular Member and Board Member

Jun 20, 2018 | Craig Burton

Why Seniors Are Paying More as Drug Prices Fall

Senate Judiciary Committee Markup - CREATES Act

Jun 14, 2018 | Rachel Schwartz

AAM Statement on Senate Judiciary Committee Vote on CREATES Act

IGBA Joins ICH Management Committee

Jun 7, 2018 | Rachel Schwartz

IGBA Joins ICH Management Committee and Welcomes the Positive Vote of the General Assembly

Jun 6, 2018 | Jeff Watson

Pass the CREATES Act to End Manipulative Practices That Cost Our Patients Billions

May 31, 2018 | Rachel Schwartz

AAM Statement on FDA REMS Guidance

America's Opioid Epidemic: Youth Awareness & Prevention at Washington, DC's Newseum May 23, 2018 - Chip Davis

May 29, 2018 | Rachel Schwartz

AAM Speaks on Involvement in the Prescription Drug Safety Network

May 22, 2018 | Erica Klinger

Gold and Platinum Hermes Awards for AAM

May 22, 2018 | Rachel Schwartz

AAM Receives Platinum and Gold Recognition from Hermes Creative Awards

May 22, 2018 | Rachel Schwartz

AAM Statement on Avalere Medicare Analysis

AAM Amicus Brief

May 21, 2018 | Rachel Schwartz

SAINT REGIS MOHAWK TRIBE and ALLERGAN, INC. v. MYLAN PHARMACEUTICALS, INC ., TEVA PHARMACEUTICALS USA, INC., and AKORN, INC.